Christos S Karapetis Selected Research

Christos S Karapetis Research Topics

Disease

44	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 11/2007
39	Neoplasms (Cancer) 01/2024 - 10/2008
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 11/2015
6	Adenocarcinoma 01/2023 - 01/2018
4	Diarrhea 12/2023 - 10/2012
4	Neoplasm Metastasis (Metastasis) 10/2021 - 11/2017
3	Dysbiosis 01/2022 - 10/2020
3	Carcinoma (Carcinomatosis) 10/2020 - 12/2010
3	Disease Progression 12/2018 - 11/2007
3	Exanthema (Rash) 07/2014 - 11/2007
2	Overweight 03/2024 - 10/2015
2	Fatigue 12/2022 - 01/2018
2	Neutropenia 12/2022 - 10/2012
2	Breast Neoplasms (Breast Cancer) 12/2022 - 01/2019
2	Hypertension (High Blood Pressure) 12/2019 - 10/2012
2	Body Weight (Weight, Body) 12/2018 - 11/2017
1	Turcot syndrome 01/2023
1	COVID-19 01/2023
1	Stomatitis 12/2022
1	Rectal Neoplasms (Rectal Cancer) 03/2022
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Infections 10/2020
1	Malignant Mesothelioma 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Mesothelioma 01/2020
1	Cardiotoxicity 01/2019
1	Heart Failure 01/2019
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2018
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2018
1	Vitamin D Deficiency 01/2018
1	Pneumonia (Pneumonitis) 11/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 03/2015

Drug/Important Bio-Agent (IBA)

17	Cetuximab (Erbitux)FDA Link 04/2024 - 11/2007
12	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2013
9	Monoclonal AntibodiesIBA 03/2016 - 11/2007
8	ErbB Receptors (EGF Receptor)IBA 12/2022 - 11/2007
7	Bevacizumab (Avastin)FDA Link 01/2022 - 10/2012
7	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
5	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 06/2013
4	atezolizumabIBA 01/2022 - 01/2020
4	Proton Pump InhibitorsIBA 01/2022 - 10/2020
4	Irinotecan (Camptosar)FDA LinkGeneric 12/2018 - 11/2007
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 10/2020
3	MicroRNAs (MicroRNA)IBA 05/2021 - 09/2018
3	Circulating Tumor DNAIBA 01/2021 - 01/2018
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 12/2010
3	durvalumabIBA 01/2020 - 11/2017
3	Codon (Codons)IBA 01/2016 - 10/2010
3	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2015 - 11/2007
2	Antiviral Agents (Antivirals)IBA 01/2023 - 11/2022
2	Phosphotransferases (Kinase)IBA 01/2023 - 10/2021
2	entrectinibIBA 10/2021 - 01/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 10/2012
2	PlatinumIBA 11/2017 - 04/2012
2	Tyrosine Kinase InhibitorsIBA 08/2017 - 10/2012
2	Panitumumab (Vectibix)FDA Link 01/2016 - 12/2014
2	Growth Factor ReceptorsIBA 02/2013 - 04/2009
1	brivanibIBA 12/2023
1	Ritonavir (Norvir)FDA Link 01/2023
1	GenieIBA 01/2023
1	Letrozole (Femara)FDA LinkGeneric 12/2022
1	Estrogen ReceptorsIBA 12/2022
1	palbociclibIBA 12/2022
1	Hormones (Hormone)IBA 12/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	tyrosine receptor (receptor, tyrosine)IBA 10/2021
1	AntibodiesIBA 01/2020
1	Pemetrexed (MTA)FDA Link 01/2020
1	RamucirumabIBA 12/2019
1	DiterpenesIBA 12/2019
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2019
1	EstersIBA 12/2019
1	AfatinibIBA 10/2018
1	Hemoglobins (Hemoglobin)IBA 10/2018
1	antineoplaston A10 (A 10)IBA 09/2018
1	hydroxide ionIBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	B7-H1 AntigenIBA 11/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2015
1	regorafenibIBA 12/2014
1	afliberceptIBA 12/2014
1	linifanibIBA 09/2014

Therapy/Procedure

35	Drug Therapy (Chemotherapy) 03/2024 - 10/2008
34	Therapeutics 03/2024 - 01/2010
11	Radiotherapy 03/2022 - 01/2009
6	Chemoradiotherapy 03/2022 - 11/2015
5	Immunotherapy 03/2024 - 01/2020
3	Neoadjuvant Therapy 01/2023 - 09/2018
2	Esophagectomy 09/2018 - 01/2009
1	Transplantation 11/2022
1	Combination Drug Therapy (Combination Chemotherapy) 03/2022
1	Segmental Mastectomy (Lumpectomy) 01/2022
1	Metastasectomy 01/2021
1	Cardiac Rehabilitation 01/2019
1	Palliative Care (Palliative Therapy) 01/2019
1	Precision Medicine 01/2018
1	Biological Therapy 01/2016